Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 227 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Integrated Treatment Clear all

Conditions: Adult Liver Carcinoma, Malignant Pancreatic Neoplasm, Prostate Carcinoma
Interventions: Cone-Beam Computed Tomography, 3-Dimensional Ultrasound-Guided Radiation Therapy; Device · Radiation
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 19 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Asthma
Interventions: Albuterol eMDPI DS, albuterol; Drug
Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.; Industry
Eligibility: 13 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 29
States / cities: Birmingham, Alabama • Los Angeles, California • Stockton, California + 24 more

Conditions: Back Pain, Depression
Interventions: Cognitive behavioral therapy, Antidepressants, Problem solving therapy; Behavioral · Drug
Lead sponsor: Kaiser Permanente; Other
Eligibility: 25 Years to 74 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cocaine Dependence, Depressive Disorder, Major
Interventions: Bupropion; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Musculoskeletal Injury
Interventions: Passive Dynamic Brace; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 370 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Parent Focused Training (PFT), Child Life and Attention Skills (CLAS) Program; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 7 Years to 11 Years
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Berkeley, California • San Francisco, California

Conditions: Covid-19 Vaccination
Interventions: Vaccine choice message, Vaccine choice + platform-framed message, Vaccine choice + HCP trust-framed message, Vaccine choice + reactogenicity-framed message; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 1,300,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Medication Adherence, Health Literacy, Geriatric Patient Care Improvement, Pharmacy Economic Improvement
Interventions: Medication adherence consultation, Medication problems assessment, Beer's Criteria Assessment, Health Literacy Assessment; Behavioral · Other
Lead sponsor: VascuScript Pharmacy; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Cheektowaga, New York

Conditions: Pancreatic Cancer
Interventions: ALT-803, ETBX-011, GI-4000, haNK for infusion, avelumab, bevacizumab, Capecitabine, Cyclophosphamide, Fluorouracil, Leucovorin, nab-Paclitaxel, lovaza, Oxaliplatin, SBRT; Biological · Drug · Procedure
Lead sponsor: ImmunityBio, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: El Segundo, California

Conditions: Alcohol Misuse
Interventions: Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care, Primary care usual care; Behavioral
Lead sponsor: Syracuse VA Medical Center; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Substance Abuse, Trauma, Post Traumatic Stress Disorder, Integrated Treatment, Incarcerated Women
Interventions: Helping Women Recover/Beyond Trauma; Behavioral
Lead sponsor: University of Tulsa; Other
Eligibility: 18 Years and older · Female only
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Taft, Oklahoma

Conditions: CARES, Standard of Care
Interventions: CARES, Standard of Care (SOC); Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 1,750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Inflammatory Bowel Disease
Interventions: Integrated Brief Behavior Therapy (IBBT) Intervention, Treatment as usual; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 12 Years to 21 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Substance-related Disorders, Drug Addiction, Human Immunodeficiency Virus, AIDS, HIV Infections
Interventions: Physician Management, Counseling; Other · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence
Interventions: AB-2100; Biological
Lead sponsor: Arsenal Biosciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 8
States / cities: Duarte, California • Tampa, Florida • Iowa City, Iowa + 4 more

Conditions: Sturge-Weber Syndrome
Interventions: Not listed
Lead sponsor: University of Illinois Chicago; Other
Eligibility: Not listed
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 8
States / cities: San Francisco, California • Chicago, Illinois • Baltimore, Maryland + 5 more

Conditions: PTSD, Chronic Pain
Interventions: Integrated Treatment for PTSD and Chronic Pain; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Hepatitis C, Illicit Drug Use
Interventions: Collaborative, multidisciplinary, integrated care; Other
Lead sponsor: Brian Edlin; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Depression
Interventions: Behavioral intervention (iCBT + TeleCoach), Internet-based cognitive behavioral therapy (I-CBT), Treatment as usual / Wait-list control; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 19 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prostate Cancer, Cancer of the Prostate
Interventions: Ethos Varian treatment system, Adaptive stereotactic body radiotherapy, Androgen deprivation therapy; Device · Radiation · Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Male only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Depression
Interventions: Veterans Work and Health Initiative; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Coatesville, Pennsylvania • Philadelphia, Pennsylvania

Conditions: Gaucher Disease
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 3 Months to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Asthma in Children
Interventions: AsthmaTuner, Asthma-Guidance and Prediction System; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 6 Years to 17 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: PET CT
Interventions: Not listed
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Charleston, South Carolina

Search by objective public record fields.

KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma

Combined Interventions for Treating Depression and Chronic Back Pain

Integrated Treatment for Cocaine and Mood Disorders - 1

Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders

Effectiveness of a Behavioral Treatment Program for Attention Deficit Hyperactivity Disorder, Inattentive Type

Effect of Messaging on Pragmatic Outcomes Within an Integrated Healthcare System

Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice

QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Brief Alcohol Treatment for Women Veterans in Primary Care

Substance Abuse and Trauma in Incarcerated Women

Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES

Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems

Buprenorphine and Integrated HIV Care

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome

Integrated PTSD and Chronic Pain Treatment

Hepatitis C Treatment in Underserved Populations

Effectiveness of a Technology Assisted Behavioral Intervention in Assisting People With Major Depressive Disorder

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

Reducing the Burden of Depression Related Disability

Advancing Integrated Therapies for Gaucher Disease

A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old Patients

PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer